Status:
COMPLETED
A Community-based Assessment of Skin Care, Allergies, and Eczema
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
University of Wisconsin, Madison
University of Colorado, Denver
Conditions:
Atopic Dermatitis
Atopic Disorders
Eligibility:
All Genders
1-63 years
Phase:
NA
Brief Summary
Atopic dermatitis (AD) affects over 9 million children in the U.S. and often heralds the development of asthma, food allergy, skin infections and neurodevelopmental disorders. Recent advances identify...
Detailed Description
AD affects over 9 million children in the U.S. and ranks first among all skin conditions in global disability burden. AD often heralds the development of several comorbidities including asthma, food a...
Eligibility Criteria
Inclusion
- Parent can provide electronic signed and dated informed consent form.
- Parent is willing and able to comply with all study procedures for the duration of the study.
- Parent is a primary caretaker of an infant 0 to 2 months of age.
- Parent is 18 years of age or older at time of consent.
- Parent can speak, read, and write in English or Spanish.
- Parent has a valid e-mail address or phone that can receive text messages
- Parent has reliable access to the internet.
- Infant is a patient of a participating Meta-LARC clinic site at the time of consent.
Exclusion
- Infant was born at less than 25 weeks gestational age.
- Infant has established eczema as diagnosed by the primary healthcare provider at clinic site of enrollment per parent report.
- Infant has known adverse reaction to petrolatum-based emollients.
- Infant has an immunodeficiency genetic syndrome such as Wiskott-Aldrich Syndrome or Severe Combined Immunodeficiency Syndrome.
- Infant has extremely low birth weight (less than 1000g or 2.2 lbs at birth).
- Infant has a sibling enrolled in the study.
- Parent is unwilling or unable to comply with study procedures.
Key Trial Info
Start Date :
July 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
1260 Patients enrolled
Trial Details
Trial ID
NCT03409367
Start Date
July 16 2018
End Date
January 31 2024
Last Update
August 15 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado-Denver
Denver, Colorado, United States, 80045
2
Duke University
Durham, North Carolina, United States, 27705
3
Oregon Health & Science University
Portland, Oregon, United States, 97239
4
University of Wisconsin-Madison
Madison, Wisconsin, United States, 53175